Case report: artificial elevation of prothrombin time by telavancin
about
Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogensFDA-approved drugs that interfere with laboratory tests: A systematic search of US drug labels.Impact of telavancin on prothrombin time and activated partial thromboplastin time as determined using point-of-care coagulometers.
P2860
Case report: artificial elevation of prothrombin time by telavancin
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Case report: artificial elevation of prothrombin time by telavancin
@ast
Case report: artificial elevation of prothrombin time by telavancin
@en
type
label
Case report: artificial elevation of prothrombin time by telavancin
@ast
Case report: artificial elevation of prothrombin time by telavancin
@en
prefLabel
Case report: artificial elevation of prothrombin time by telavancin
@ast
Case report: artificial elevation of prothrombin time by telavancin
@en
P2093
P2860
P1476
Case report: artificial elevation of prothrombin time by telavancin
@en
P2093
Derek F Amanatullah
Matthew J Lopez
Munish C Gupta
Robert C Gosselin
P2860
P2888
P304
P356
10.1007/S11999-012-2612-0
P407
P577
2012-11-06T00:00:00Z